Novo Nordisk’s Wegovy Pill Wins U.S. Approval
Novo Nordisk received approval from the U.S. FDA for the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events. The Wegovy pill is …